 Hoth Therapeutics, Inc. NASDAQ: HOTH, a biopharmaceutical company, today is providing shareholders with a update on its COVID-19 initiatives including vaccine and real-time, breath-based mobile testing device as well as its dermatological therapy pipeline. 